There are a number of similarities and differences. Great Britain opted to deploy all its efforts from the outset. In mid-February, it held a meeting in Geneva and invited a handful of international representatives, including myself. From the get-go, Great Britain decided to provide maximum support to three initiatives, one being the AstraZeneca vaccine, which is in production and has been approved in more than 50 countries to date. The vaccine is a real success story, and I think part of that success is attributable to the development model: an academic lab with high-tech facilities and equipment and a major pharmaceutical company joining forces backed by the British government. That's where our approach and Great Britain's diverge.
On February 25th, 2021. See this statement in context.